Ignite Creation Date:
2025-12-25 @ 3:10 AM
Ignite Modification Date:
2026-03-01 @ 12:05 PM
Study NCT ID:
NCT06702605
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-11-25
First Post:
2024-11-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
To Evaluate XNW5004 Tablets in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma
Sponsor:
Evopoint Biosciences Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-11
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-11-20
First Submit QC Date:
None
Study First Post Date:
2024-11-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-22
Last Update Post Date:
2024-11-25
Last Update Post Date Type:
ACTUAL